Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 28Terminated 5Active not recruiting 3Withdrawn 2Recruiting 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Non-Small-Cell Lung 49Breast Neoplasms 39Ovarian Neoplasms 35Triple Negative Breast Neoplasms 24Endometrial Neoplasms 20Stomach Neoplasms 19Squamous Cell Carcinoma of Head and Neck 17Lung Neoplasms 17Fallopian Tube Neoplasms 17Esophageal Squamous Cell Carcinoma 15Esophageal Neoplasms 15Neoplasms 14Neoplasm Metastasis 14Parkinson Disease 4, Autosomal Dominant Lewy Body 13Uterine Cervical Neoplasms 12Carcinoma, Ovarian Epithelial 10Head and Neck Neoplasms 7Recurrence 6Colorectal Neoplasms 6Carcinoma 6Adenocarcinoma 5Uterine Neoplasms 4Small Cell Lung Carcinoma 4Oropharyngeal Neoplasms 4Melanoma 4Carcinoma, Transitional Cell 4Carcinoma, Squamous Cell 4Advanced Solid Tumors 4Adenocarcinoma Of Esophagus 4Peritoneal Neoplasms 3

Interventions

pembrolizumab 20Gemcitabine 18Cisplatin 14enfortumab vedotin 12Magnetic Resonance Spectroscopy 12Specimen Handling 10Cystectomy 10Docetaxel 8Mitomycin 7Standard of Care 6Cystoscopy 6Transurethral Resection of Bladder 5Radiotherapy 5Carboplatin 5durvalumab 4Practice Guidelines as Topic 4Nivolumab 4Radiation 3Multiparametric Magnetic Resonance Imaging 3Mitozytrex 3Fluorouracil 3tislelizumab 2dehydroftorafur 2cemiplimab 2avelumab 2alvimopan 2Therapeutics 2Surveys and Questionnaires 2Surgical Procedures, Operative 2Radiosurgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Urinary Bladder Neoplasms × Paclitaxel × Clear all
NCT07419295 2026-05-22

TroFuse-031

Merck Sharp & Dohme LLC

Phase 3 Recruiting
590 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06173349 2026-03-13

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

University of California, Davis

Phase 1 Recruiting
12 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡